The Town of Normal has been awarded the Bloomberg Philanthropies "What Works Cities" silver certification for using data to ...

HUTCHMED reported positive Phase 3 trial results for sovleplenib in autoimmune anemia, supporting a planned China drug filing in 2026 as competition in blood disorders intensifies.

Miggo’s researchers describe the methodology as a form of indirect prompt injection leading to an authorization bypass. The ...

This news release constitutes a “designated news release” for the purposes of the Company’s amended and restated prospectus ...

The pivotal U.S. jobs report for December is supposed to be the first normal one since the government shutdown, but it could prove devilishly hard for investors to parse. How come? The effects of the ...

Scientists claim that first extraterrestrial contact will be a loud event impossible to ignore, not a subtle signal.

In many modern applications, weather data directly affects system behavior rather than simply enhancing the interface.

Editor’s Note: This interview first appeared in Path Finders, an email newsletter from the Daily Yonder. Each week, Path ...

The fast evolution of technology in the areas of Artificial Intelligence (AI), Data Analytics, and cloud computing has changed the way we measure, understand, a ...

First Trust Intermediate Duration Preferred & Income Fund (the "Fund") (NYSE: FPF) has declared the Fund’s regularly scheduled monthly common share distribution in the amount of $0.1375 per share ...